Table 1.

Background and symptoms of the subjects.

Sample	Age	Sex	Period between Occurrence and Blood Collection		Stroke Features				Treatment			Risk Factors
			1st (P-group)	2nd (T-group)	Stroke Type		Severity	Post-Stroke Conditions	Tissue Plasminogen Activator	Edaravone	HeparinOzagrel-Sodium	Other Diseases					SM
					Lacunar	Emboli	NIHSS	mRS				HT	DM	DL	IHD	AF
P4 -> T4	79	f	3	18		+	6	2			+	+	+	+
P3 -> T3	74	m	3	21	+		4	2			+	+	+
P5 -> T5	84	m	2	15		+	4	1		+	+	+	+
P11 -> T11	78	m	1	18	+		1	0			+	+	+
P2 -> T2	82	m	1	28		+	1	1		+	+		+		+		+
P13 -> T13	39	m	1	16	+		2	1	+	+	+			+
P1 -> T1	73	m	1	13	+		5	1		+	+						+
P6	50	m	1		+		1					+	+	+			+
P8	63	f	1		+		1					+	+	+			+
P16	78	m	3		+		5					+	+	+	+	+	+
P27	70	m	2			+	12					+	+	+	+
P20	50	f	2		+		3					+	+
P7	65	m	5			+	7					+		+	+		+
P10	81	m	5		+		4					+		+		+
P12	86	f	3			+	2					+		+
P22	70	m	5		+		1					+		+
P23	49	m	1		+		1					+		+			+
P9	77	f	1		+		5					+					+
P14	57	m	10		+		2						+
P18	71	m	7			+	6						+	+	+
P24	83	m	1			+	12						+			+
P25	90	f	ND		+		6						+
P17	28	m	2			+	7									+
Total = 23	Ave.± SD = 68.6 ± 15.8	m/f =17/6			14	9	Ave.± SD = 4.26 ± 3.14	Ave.± SD = 1.14 ± 0.639	1	4	7	15	14	11	5	4	8
C16	75	m										+	+	+			+
C1	74	m										+	+		+
C2	80	m										+	+
C24	85	m										+	+
C7	61	m										+		+
C27	72	m										+			+
C4	80	f										+
C9	78	f										+
C11	76	m										+
C12	90	f										+
C22	66	m										+
C18	73	m											+				+
C6	51	m															+
C14	61	m															+
C3	79	m
C5	83	m
C10	82	m
C13	40	m
C17	26	m
C20	55	f
C23	46	m
C25	89	f
Total = 22	Ave.± SD = 69.2 ± 16.4	m/f = 17/5										11	5	2	2	0	4

HT: Hypertension / DL: Dyslipidemia / DM: Diabetes Mellitus / AF: Atrial fibrillation / IHD: Ischemic Heart Disease / SM: Smoking Habit.